CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
30 MMWR June 18, <strong>2010</strong><br />
433. el-Raghy L, Black DJ, Osman F, Orme ML, Fathalla M. <strong>Contraceptive</strong><br />
steroid concentrations in women with early active schistosomiasis: lack<br />
of effect of antischistosomal drugs. Contraception 1986;33:373–7.<br />
434. Gad-el-Mawla N, Abdallah A. Liver function in bilharzial females<br />
receiving contraceptive pills. Acta Hepato 1969;16:308–10.<br />
435. Gad-el-Mawla N, el-Roubi O, Sabet S, Abdallah A. Plasma lipids and<br />
lipoproteins in bilharzial females during oral contraceptive therapy. J<br />
Egypt Med Assoc 1972;55:137–47.<br />
436. Shaaban MM, Hammad WA, Falthalla MF, et al. Effects of oral contraception<br />
on liver function tests and serum proteins in women with<br />
active schistosomiasis. Contraception 1982;26:75–82.<br />
437. Shaaban MM, Ghaneimah SA, Mohamed MA, Abdel-Chani S, Mostafa<br />
SA. Effective of oral contraception on serum bile acid. Int J Gynaecol<br />
Obstet 1984;22:111–5.<br />
438. Sy FS, Osteria TS, Opiniano V, Gler S. Effect of oral contraceptive on<br />
liver function tests of women with schistosomiasis in the Philippines.<br />
Contraception 1986;34:283–94.<br />
439. Tagy AH, Saker ME, Moussa AA, Kolgah A. The effect of low-dose<br />
combined oral contraceptive pills versus injectable contracetpive (Depot<br />
Provera) on liver function tests of women with compensated bilharzial<br />
liver fibrosis. Contraception 2001;64:173–6.<br />
440. Beck P, Wells SA. Comparison of the mechanisms underlying carbohydrate<br />
intolerance in subclinical diabetic women during pregnancy<br />
and during post-partum oral contraceptive steroid treatment. J Clin<br />
Endocrinol Metab 1969;29:807–18.<br />
441. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type<br />
2 diabetes mellitus in Latina women with prior gestational diabetes<br />
mellitus. JAMA 1998;280:533–8.<br />
442. Kung AW, Ma JT, Wong VC, et al. Glucose and lipid metabolism<br />
with triphasic oral contraceptives in women with history of gestational<br />
diabetes. Contraception 1987;35:257–69.<br />
443. Radberg T, Gustafson A, Skryten A, Karlsson K. Metabolic studies in<br />
gestational diabetic women during contraceptive treatment: effects on<br />
glucose tolerance and fatty acid composition of serum lipids. Gynecol<br />
Obstet Invest 1982;13:17–29.<br />
444. Skouby SO, Molsted-Pedersen L, Kuhl C. Low dosage oral contraception<br />
in women with previous gestational diabetes. Obstet Gynecol<br />
1982;59:325–8.<br />
445. Skouby SO, Andersen O, Kuhl C. Oral contraceptives and insulin<br />
receptor binding in normal women and those with previous gestational<br />
diabetes. Am J Obstet Gynecol 1986;155:802–7.<br />
446. Skouby SO, Andersen O, Saurbrey N, Kuhl C. Oral contraception<br />
and insulin sensitivity: in vivo assessment in normal women and<br />
women with previous gestational diabetes. J Clin Endocrinol Metab<br />
1987;64:519–23.<br />
447. Xiang AH, Kawakubo M, Kjos SL, Buchanan TA. Long-acting<br />
injectable progestin contraception and risk of type 2 diabetes in<br />
Latino women with prior gestational diabetes mellitus. Diabetes Care<br />
2006;29:613–7.<br />
448. Kjos SL, Shoupe D, Douyan S, et al. Effect of low-dose oral contraceptives<br />
on carbohydrate and lipid metabolism in women with recent<br />
gestational diabetes: results of a controlled, randomized, prospective<br />
study. Am J Obstet Gynecol 1990;163:1822–7.<br />
449. Radberg T, Gustafson A, Skryten A, Karlsson K. Metabolic studies<br />
in women with previous gestational diabetes during contraceptive<br />
treatment: effects on serum lipids and high density lipoproteins. Acta<br />
Endocrinol (Copenh) 1982;101:134–9.<br />
450. Skouby SO, Kuhl C, Molsted-Pedersen L, Petersen K, Christensen<br />
MS. Triphasic oral contraception: metabolic effects in normal women<br />
and those with previous gestational diabetes. Am J Obstet Gynecol<br />
1985;153:495–500.<br />
451. Beck P, Arnett DM, Alsever RN, Eaton RP. Effect of contraceptive steroids<br />
on arginine-stimulated glucagon and insulin secretion in women.<br />
ll. Carbohydrate and lipid phsiology in insulin-dependent diabetics.<br />
Metabolism 1976;25:23–31.<br />
452. Diab KM, Zaki MM. Contraception in diabetic women: comparative<br />
metabolic study of norplant, depot medroxyprogesterone acetate,<br />
low dose oral contraceptive pill and CuT380A. J Obstet Gynecol Res<br />
2000;26:17–26.<br />
453. Garg SK, Chase P, Marshall G, et al. Oral contraceptives and renal and<br />
retinal complications in young women with insulin-dependent diabetes<br />
mellitus. JAMA 1994;271:1099–102.<br />
454. Grigoryan OR, Grodnitskaya EE, Andreeva EN, et al. Contraception<br />
in perimenopausal women with diabetes mellitus. Gynecol Endocrinol<br />
2006;22:198–206.<br />
455. Margolis KL, Adami H-O, Luo J, Ye W, Weiderpass E. A prospective<br />
study of oral contraceptive use and risk of myocardial infarction among<br />
Swedish women. Fertil Steril 2007;88:310–6.<br />
456. Petersen KR, Skouby SO, Sidelmann J, Jespersen J. Assessment of<br />
endothelial function during oral contraception on women with insulindependent<br />
diabetes mellitus. Metabolism 1994;43:1379–83.<br />
457. Petersen KR, Skouby SO, Jespersen J. Balance of coagulation activity<br />
with fibrinolysis during use of oral contraceptives in women with<br />
insulin-dependent diabetes millitus. Int J Fertil 1995;40:105–11.<br />
458. Radberg T, Gustafson A, Skryten A, Karlsson k. Oral contraception<br />
in diabetic women. A cross-over study on seum and high density<br />
lipoprotein (HDL) lipids and diabetes control during progestogen<br />
and combined estrogen/progestogen contraception. Horm Metab Res<br />
1982;14:61–5.<br />
459. Skouby SO, Jensen BM, Kuhl C, et al. Hormonal contraception in<br />
diabetic women: acceptability and influence on diabetes control and<br />
ovarian function of a nonalkylated estrogen/progestogen compound.<br />
Contraception 1985;32:23–31.<br />
460. Skouby SO, Molsted-Petersen L, Kuhl C, Bennet P. Oral contraceptives<br />
in diabetic womne: metabolic effects of four compounds with different<br />
estrogen/progestogen profiles. Fertil Steril 1986;46:858–64.<br />
461. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological,<br />
and histologic parameters as predictors of relapse in ulcerative colitis.<br />
Gastroenterology 2001;120:13–20.<br />
462. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive<br />
use and the clinical course of Crohn’s disease: a prospective<br />
cohort study. Gut 1999;45:218–22.<br />
463. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of oral contraceptive<br />
use on reoperation following surgery <strong>for</strong> Crohn’s disease. Dig<br />
Dis Sci 1992;37:1377–82.<br />
464. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and<br />
smoking are risk factors <strong>for</strong> relapse in Crohn’s disease. The Canadian<br />
Mesalamine <strong>for</strong> Remission of Crohn’s Disease Study Group.<br />
Gastroenterology 1998;114:1143–50.<br />
465. Wright JP. Factors influencing first relapse in patients with Crohn’s<br />
disease. J Clin Gastroenterol 1992;15:12–6.<br />
466. Grimmer SF, Back DJ, Orme ML, et al. The bioavailability of<br />
ethinyloestradiol and levonorgestrel in patients with an ileostomy.<br />
Contraception 1986;33:51–9.